2021
DOI: 10.3390/nu13010162
|View full text |Cite
|
Sign up to set email alerts
|

Application of Ligilactobacillus salivarius CECT5713 to Achieve Term Pregnancies in Women with Repetitive Abortion or Infertility of Unknown Origin by Microbiological and Immunological Modulation of the Vaginal Ecosystem

Abstract: In this study, the cervicovaginal environment of women with reproductive failure (repetitive abortion, infertility of unknown origin) was assessed and compared to that of healthy fertile women. Subsequently, the ability of Ligilactobacillus salivarius CECT5713 to increase pregnancy rates in women with reproductive failure was evaluated. Vaginal pH and Nugent score were higher in women with reproductive failure than in fertile women. The opposite was observed regarding the immune factors TGF-β 1, TFG-β 2, and V… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
17
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
2
1

Relationship

2
7

Authors

Journals

citations
Cited by 17 publications
(18 citation statements)
references
References 135 publications
(184 reference statements)
1
17
0
Order By: Relevance
“…In another study, Ligilactobacillus salivarius CECT5713 (formerly Lactobacillus salivarius) was administered daily for 6 months to 44 pregnant women either with a history of recurrent miscarriages or infertility with abnormal VMB and vaginal pH at baseline. The intervention resulted in 56% of successful pregnancy rate in these women and those with full-term pregnancy had significant increase in vaginal lactobacilli, decrease in vaginal pH, and Nugent score after intervention, suggesting probiotic's ability to balance VMB and support healthy pregnancy in women with fertility issues (Fernández et al, 2021). Women with unexplained infertility diagnosis and receiving a 4-week probiotic supplementation of L. crispatus LbV 88, L. rhamnosus LbV 96, L. jensenii LbV 116, and L. gasseri LbV 150N had no change in overall VMB diversity or composition when compared with controls (Schenk et al, 2021).…”
Section: Probioticsmentioning
confidence: 89%
“…In another study, Ligilactobacillus salivarius CECT5713 (formerly Lactobacillus salivarius) was administered daily for 6 months to 44 pregnant women either with a history of recurrent miscarriages or infertility with abnormal VMB and vaginal pH at baseline. The intervention resulted in 56% of successful pregnancy rate in these women and those with full-term pregnancy had significant increase in vaginal lactobacilli, decrease in vaginal pH, and Nugent score after intervention, suggesting probiotic's ability to balance VMB and support healthy pregnancy in women with fertility issues (Fernández et al, 2021). Women with unexplained infertility diagnosis and receiving a 4-week probiotic supplementation of L. crispatus LbV 88, L. rhamnosus LbV 96, L. jensenii LbV 116, and L. gasseri LbV 150N had no change in overall VMB diversity or composition when compared with controls (Schenk et al, 2021).…”
Section: Probioticsmentioning
confidence: 89%
“…In semen, high concentrations of TGF-β1 and TGF-β2 can regulate women’s immune tolerance to sperm, embryo implantation, and subsequent pregnancy. After intercourse, the pH of the vagina will activate TGF-β-involved immune tolerance ( 100 ). Furthermore, existing studies show that TGF-β seems to be a factor controlling the apoptosis and proliferation of endometrial cells during the process of embryo implantation.…”
Section: Tgf-β1 In Pathological Pregnancymentioning
confidence: 99%
“…Microbiological analyses of six batches showed that the fermented product only contained L. salivarius MP101 and contained the appropriate amount of viable probiotic cells considered valid for the assay (≥9 log 10 CFU/container) for five weeks, provided that the probiotic dairy product was stored at refrigeration temperatures. L. salivarius is a species that contains strains with a high probiotic potential, as assessed by in vitro and in vivo assays and clinical trials [ 27 , 28 , 29 , 30 ]. However, very few strains are commercially available because of their short stability at room temperature.…”
Section: Discussionmentioning
confidence: 99%